CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Autor principal: | Eva, Israt Ara Jannat |
---|---|
Outros Autores: | Rahman, Kazi Fatema |
Formato: | Thesis |
Idioma: | English |
Publicado em: |
Brac University
2023
|
Assuntos: | |
Acesso em linha: | http://hdl.handle.net/10361/17764 |
Registos relacionados
-
A review on CRISPR-Cas system based applications in Oncology
Por: Sadia, Mir
Publicado em: (2022) -
CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
Por: Maria, Amatul
Publicado em: (2020) -
Comparative analysis of CRISPR-Cas systems of Yersinia pestis and Escherichia coli strains. (November 2020 – December 2021)
Por: Nwabunwanne, Eze Uchenna
Publicado em: (2022) -
Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
Por: Shaikat, Mahdi Mubin
Publicado em: (2023) -
CRISPR/Cas9 genome editing to treat sickle cell disease
Por: Ullah, Mohammad
Publicado em: (2023)